Flagler Health Raises $50M Series B for MSK AI Platform

Flagler Health has successfully closed a $50 million Series B funding round, propelling its mission to revolutionize musculoskeletal (MSK) care through an AI-native operating system. This significant capital infusion, led by Bessemer Venture Partners, with crucial participation from SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Ventures, and Offscript, brings the company's total funding to $63 million. The investment underscores a strong market belief in Flagler's approach to tackling systemic inefficiencies within the vast MSK sector.

The musculoskeletal market represents a substantial economic force in healthcare, with conditions affecting over half of U.S. adults and generating annual expenditures exceeding $400 billion. Despite this, healthcare providers in this specialty often grapple with significant administrative burdens, with estimates suggesting physicians dedicate nearly 75% of their time to non-clinical, non-revenue-generating tasks. Flagler Health is addressing this critical gap by developing an AI operating system designed to integrate seamlessly with existing electronic medical record (EMR) systems, thereby streamlining clinical and administrative workflows across the entire patient journey.

Flagler's platform offers a comprehensive suite of functionalities, encompassing patient intake and triage, ongoing care management, billing processes, and patient communication. The core objective is to alleviate the administrative load on clinicians, enhance operational efficiency, and ultimately improve patient outcomes. The company emphasizes that its AI models are trained on one of the most extensive MSK patient datasets available, a testament to its deep understanding of the clinical and operational challenges faced by MSK practices. This foundation was built by a team with direct experience in managing and operating these specialized healthcare facilities.

The company's technology is engineered for broad applicability, designed to function across diverse MSK practice types and various EMR environments with minimal disruption to established provider workflows. A key differentiator is its ability to operate unobtrusively in the background, automating tasks such as remote patient outcome tracking without requiring additional logins, extensive training, or manual data entry from clinicians. This focus on seamless integration and reduced user friction has contributed to rapid adoption, with Flagler Health expanding to serve thousands of providers across more than 36 states in under three years.

The impact of Flagler's platform is quantifiable. Providers utilizing the system report an average increase in annual revenue of $164,000 per provider. Furthermore, the platform demonstrates a significant positive effect on patient well-being, with 87% of patients experiencing improvements in key areas such as pain reduction, mood enhancement, better sleep, or increased mobility. This dual benefit of financial uplift for providers and enhanced patient quality of life positions Flagler Health as a transformative force in MSK care.

With this new funding, Flagler Health plans to accelerate its expansion into additional MSK practices nationwide. The company aims to solidify its position as the indispensable AI-native operating infrastructure for the entire MSK specialty. The strategic investment from a robust group of venture capital firms, including the lead Bessemer Venture Partners, signals strong confidence in Flagler's vision and its capacity to address a deeply entrenched problem within the U.S. healthcare system.